Fundamental dimension Equity attribute | CSANPeer $2.75▼-1.61% Cap $5.39BP/E -2.6x QuantScore38/100 | CRGYPeer $13.83▲+3.75% Cap $4.57BP/E 94.5x QuantScore62/100 | DHTLeader $24.60▲+1.99% Cap $3.97BP/E 8.4x QuantScore67/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
68/100 |
94/100 |
74/100 |
Valuation Multiples, PEG & DCF upside | 69/100 | 50/100 | 80/100 |
Health Piotroski, Altman Z, leverage & liquidity | 20/100 | 30/100 | 91/100 |
Growth Revenue / earnings growth & margins | 9/100 | 76/100 | 47/100 |
Sentiment Analyst ratings, targets & revisions | 26/100 | 62/100 | 44/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -2.6x | 94.5x | 8.4x |
Forward P/E (next FY) | -30.4x | 5.6x | 5.8x |
EV / EBITDA (TTM) | 13.4x | 6.7x | 7.1x |
Price / Sales | 0.7x | 1.1x | 5.5x |
Price / Free Cash Flow | 15.1x | 5.1x | 111.0x |
PEG ratio | -0.03 | -0.05 | 0.06 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 5 / 9 | 7 / 9 | 6 / 9 |
Altman Z-Score | 0.52 (Distress) | 0.80 (Distress) | 6.49 (Safe) |
Total debt / equity | 12.26 | 1.02 | 0.33 |
Quick ratio | 1.5x | 0.9x | 3.3x |
Interest coverage | 1.2x | 2.8x | 27.2x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -8.0% | +22.1% | -13.0% |
Net income growth YoY | -3.2% | +216.0% | +16.4% |
Gross margin (TTM) | 34.5% | 75.3% | 59.5% |
Operating margin (FY) | 26.5% | 13.2% | 34.2% |
FCF margin (FY) | 0.2% | -2.5% | -6.7% |
5. Trailing price performancePrice change over period |
1M return | 0.0% | +3.1% | +13.5% |
3M return | -9.8% | +22.7% | +33.3% |
6M return | -34.4% | +8.6% | +36.2% |
Year to date | -30.4% | +64.8% | +101.5% |
1Y return | -36.5% | +65.0% | +96.8% |
3Y return | -77.6% | +14.5% | +125.9% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $5.14 +87.0% upside | $-120.62 -972.2% premium | $127.49 +418.3% upside |
Wall Street consensus target | $3.20 +16.4% · range $3.20–$3.20 | $17.88 +29.3% · range $15.00–$19.00 | $28.00 +13.8% · range $28.00–$28.00 |
Consensus stance | 0% Buy50% Hold50% Sell | 64% Buy29% Hold7% Sell | 50% Buy50% Hold0% Sell |